Showing results (21-30 of 74) with videos related to
Sort By:
Pageof 8
Journal of Medicinal Chemistry|May 1, 1985
Synthesis and interaction of 5-(substituted-phenyl)-3-methyl-6,7-dihydropyrazolo[4,3-e] [1,4]diazepin-8(7H)-ones with benzodiazepine receptors in rat cerebral cortexP G Baraldi, S Manfredini, V Periotto, et al.Farmaco (Societa Chimica Italiana : 1989)|May 13, 1999
DNA minor-groove binders: results and design of new antitumor agentsP G Baraldi, B Cacciari, A Guiotto, et al.Current Pharmaceutical Design|April 10, 1999
Heterocyclic analogs of DNA minor groove alkylating agentsP G Baraldi, B Cacciari, A Guiotto, et al.Current Medicinal Chemistry|August 27, 2010
Allosteric enhancers of A1 adenosine receptors: state of the art and new horizons for drug developmentR Romagnoli, P G Baraldi, M A Tabrizi, et al.British Journal of Pharmacology|October 23, 2009
Transient receptor potential ankyrin receptor 1 is a novel target for pro-tussive agentsE Andrè, R Gatti, M Trevisani, et al.Bioorganic & Medicinal Chemistry Letters|November 24, 1999
Resolution of a CPzI precursor, synthesis and biological evaluation of (+) and (-)-N-Boc-CPzI: a further validation of the relationship between chemical solvolytic stability and cytotoxicityP G Baraldi, B Cacciari, R Romagnoli, et al.Journal of Medicinal Chemistry|May 15, 1992
Geiparvarin analogues. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chainP G Baraldi, S Manfredini, D Simoni, et al.Arzneimittel-Forschung|April 12, 2000
DNA sequence-recognizing properties of minor groove alkylating agents. Effects of the replacement of N-methylpyrrole by an N-methylimidazole on tallimustine and its own homologueP G Baraldi, R Romagnoli, G Spalluto, et al.Antiviral Chemistry & Chemotherapy|January 6, 1999
Enzymatic synthesis of 2'-O-acyl prodrugs of 1-(beta-D-arabinofuranosyl)-5(E)-(2-bromovinyl)uracil and of 2'-O-acyl-araU, -araC and -araAS Manfredini, P G Baraldi, R Bazzanini, et al.The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonistC Zocchi, E Ongini, A Conti, et al.Pageof 8